BMC Medicine

BMC Medicine is the flagship general medical journal of the BMC series published by Springer Nature as an open access transparent peer-reviewed title since 2003 under the ISSN 1741-7015, covering all areas of clinical practice, translational medicine, public and global health and policy, with a 2025 Journal Impact Factor of 8.7 and a first quartile rank of 21 of 336 in medicine general and internal《BMC 医学》（BMC Medicine）是（BMC）系列的旗舰医学综合刊，由施普林格自然（Springer Nature）自 2003 年起出版的开放获取、透明同行评审期刊，刊号 1741-7015，覆盖临床实践、转化医学、公共卫生与全球健康及政策各领域，2025 年影响因子为 8.7，在医学综合与内科类 336 种期刊中列第 21 位、居第一四分位。

Scope

• The journal describes itself as the flagship medical journal of the BMC series and publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health advances, public health, global health, policy and general topics of interest to the biomedical and sociomedical professional communities该刊自述为（BMC）系列的旗舰医学刊，刊载临床实践、转化医学、医学与健康进展、公共卫生、全球健康、政策以及生物医学与社会医学专业群体关注议题等各方面的杰出且有影响的研究。
• Article types include research articles, systematic reviews, reviews, study protocols, case reports, data articles, opinion and commentary, and the journal welcomes submissions across the full spectrum of medical research from bench to bedside to population health文章类型包括研究论文、系统综述、综述、研究方案、病例报告、数据文章、观点与评论，该刊欢迎从基础到临床再到人群健康的医学研究全谱投稿。
• As an open access journal it applies a Creative Commons attribution licence to accepted articles and levies an article processing charge on the corresponding author, with waivers and funding support available for qualifying authors作为开放获取期刊，该刊对录用文章采用知识共享署名许可，向通讯作者收取文章处理费，并对符合条件的作者提供减免与资助支持。
• The journal operates transparent peer review, offering authors the option to publish reviewer reports and their names alongside the accepted article, and it follows the BMC editorial policies on data availability, research integrity and competing interests该刊实行透明同行评审，作者可选择在录用文章发表时一并公开审稿报告与审稿人姓名，并遵循（BMC）关于数据可获取性、研究诚信与利益冲突的编辑政策。
• It is abstracted and indexed in MEDLINE, PubMed, Science Citation Index Expanded, Scopus, EMBASE and Google Scholar, and it is included in the Journal Citation Reports from the Science Citation Index Expanded edition该刊被（MEDLINE）、（PubMed）、（SCIE）、（Scopus）、（EMBASE）与（Google Scholar）收录，并纳入（SCIE）版期刊引证报告。
• In the 2025 Journal Citation Reports it ranks 21 of 336 titles in medicine general and internal with a 93.9 percentile and its five year indicator remains in the first quartile在 2025 年版期刊引证报告中，该刊在医学综合与内科类 336 种期刊中列第 21 位、百分位 93.9，五年指标同样位于第一四分位。

History

• The journal was launched in 2003 as part of the BMC series of open access journals founded by BioMed Central, and it has operated as a fully open access title since its first volume该刊于 2003 年作为（BioMed Central）创办的（BMC）开放获取期刊系列的一部分创刊，自第一卷起即为完全开放获取期刊。
• Following the acquisition of BioMed Central by Springer in 2008 and the later formation of Springer Nature, the journal became part of the Springer Nature portfolio while retaining the BMC brand and open access model2008 年施普林格收购（BioMed Central），其后施普林格自然成立，该刊并入施普林格自然期刊群，但保留（BMC）品牌与开放获取模式。
• The Journal Impact Factor moved from 8.775 in 2021 to 11.15 in 2022, then to 8.3 in 2024 and 8.7 in 2025, maintaining first quartile standing in medicine general and internal throughout该刊影响因子由 2021 年的 8.775 升至 2022 年的 11.15，再降至 2024 年的 8.3 与 2025 年的 8.7，始终居医学综合与内科类第一四分位。
• The journal has progressively expanded its article types and editorial policies, introducing transparent peer review options and study protocol and data article formats to support open research practices该刊逐步扩展文章类型与编辑政策，引入透明同行评审选项以及研究方案与数据文章格式，以支持开放研究实践。
• The publisher carries the journal on Springer Nature Link and the digital object identifier prefix of its articles is 10.1186, shared with other BMC series journals出版方将该刊载于施普林格自然链接平台，其文章的数字对象唯一标识符前缀为（10.1186），与（BMC）系列其他期刊一致。

Editors

• The journal is led by an editor-in-chief supported by a senior editorial board and an international editorial board whose members are drawn from medical schools, research institutes and public health bodies across the world该刊由一位主编带领，配以资深编委会与由世界各地医学院、研究机构及公共卫生机构学者组成的国际编委会。
• The editorial team includes section editors and associate editors responsible for subject areas such as infectious disease, cardiology, oncology, public health and global health, reflecting the general medical scope of the journal编辑团队设有学科编辑与副编辑，分别负责感染病、心脏病学、肿瘤学、公共卫生与全球健康等方向，对应刊物的医学综合定位。
• Editorial handling follows the Springer Nature editorial management system, with submissions assigned to handling editors based on subject expertise and competing interest declarations稿件处理依托施普林格自然的编辑管理系统，依据学科专长与利益冲突声明分配责任编辑。
• Peer review is transparent and the journal maintains the BMC standards on reviewer recruitment, conflict of interest management, data sharing and editorial independence同行评审采用透明方式，该刊遵循（BMC）在审稿人遴选、利益冲突管理、数据共享与编辑独立性方面的标准。
• The masthead and board roster are published on the journal page at Springer Nature Link and updated as new members join or existing members step down编委名单在施普林格自然链接期刊页公布，并随成员增减而更新。